Abstract
Between 8% and 26% of patients starting antiretroviral therapy (ART) in programmes in sub-Saharan Africa die during the first year of ART, with the majority of deaths occurring in the first few months [1]. There is a critical need for effective interventions to reduce this [2]. In this patient group
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
